Page last updated: 2024-11-02

phloretin and Alzheimer Disease

phloretin has been researched along with Alzheimer Disease in 2 studies

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghumatkar, PJ2
Patil, SP2
Peshattiwar, V1
Vijaykumar, T1
Dighe, V1
Vanage, G1
Sathaye, S2
Jain, PD1
Tambe, RM1

Other Studies

2 other studies available for phloretin and Alzheimer Disease

ArticleYear
The modulatory role of phloretin in Aβ
    Naunyn-Schmiedeberg's archives of pharmacology, 2019, Volume: 392, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Behavior, Animal; Brain; Disease Models, Animal;

2019
Nootropic, neuroprotective and neurotrophic effects of phloretin in scopolamine induced amnesia in mice.
    Pharmacology, biochemistry, and behavior, 2015, Volume: 135

    Topics: Acetylcholinesterase; Alzheimer Disease; Amnesia; Animals; Antioxidants; Brain-Derived Neurotrophic

2015